to further characterize this cellular eia-like activity , we analyzed expression of the eiiae promoter as well as the binding activity of the cognate e2f transcription factor after infection of f9 embryonal carcinoma cells and their differentiated derivatives with wild-type adenovirus , eia ( dl312 ) , or eiv ( dl808 ) deletion mutants .
C0007634
cellular
C0007589
differentiated